Sudershan Drugs And Intermediates Profile
Key Indicators
- Authorised Capital ₹ 13.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 13.50 Cr
as on 16-11-2024
- Company Age 41 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 53.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.00 Cr
as on 16-11-2024
- Revenue 0.77%
(FY 2023)
- Profit -8.95%
(FY 2023)
- Ebitda -6.01%
(FY 2023)
- Net Worth -7.26%
(FY 2023)
- Total Assets -0.39%
(FY 2023)
About Sudershan Drugs And Intermediates
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.50 Cr and a paid-up capital of Rs 13.50 Cr.
The company currently has active open charges totaling ₹53.00 Cr. The company has closed loans amounting to ₹11.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sudershan Drugs And Intermediates Limited India are Subbaraju Gokaraju as CFO and Priya Khetan as Company Secretary. Yoganandavenkata Subrahamanya, Appala Chilakanarri, and Subbaraju Gokaraju serve as directors at the Company.
- CIN/LLPIN
U24230TG1982PLC003759
- Company No.
003759
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Dec 1982
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sudershan Drugs And Intermediates Limited offer?
Sudershan Drugs And Intermediates Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Sudershan Drugs And Intermediates?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yoganandavenkata Subrahamanya  | Managing Director | 22-Dec-2017 | Current |
| Subbaraju Gokaraju | CFO | 01-Sep-2020 | Current |
| Priya Khetan | Company Secretary | 13-Jun-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Appala Chilakanarri | Director | 15-May-2005 | Current |
| Subbaraju Gokaraju | Director | 30-Sep-1994 | Current |
Financial Performance of Sudershan Drugs And Intermediates.
Sudershan Drugs And Intermediates Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.77% increase. The company also saw a slight decrease in profitability, with a 8.95% decrease in profit. The company's net worth dipped by a decrease of 7.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sudershan Drugs And Intermediates?
In 2023, Sudershan Drugs And Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Siris LimitedActive 58 years 6 daysYoganandavenkata Subrahamanya, Appala Chilakanarri and 1 more are mutual person
- Agriman Foods Private LimitedActive 2 years 3 months
Yoganandavenkata Subrahamanya and Subbaraju Gokaraju are mutual person
- Vaarahi Agri Private LimitedActive 2 years 3 months
Yoganandavenkata Subrahamanya and Subbaraju Gokaraju are mutual person
- Gamma Organics LimitedActive 23 years 1 month
Yoganandavenkata Subrahamanya and Subbaraju Gokaraju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Gr Intrachem Ltd Creation Date: 27 Dec 2000 | ₹12.00 Cr | Open |
Gr Intrachem Ltd Creation Date: 30 Mar 2000 | ₹5.00 Cr | Open |
Canara Bank Creation Date: 06 Dec 1997 | ₹20.00 Cr | Open |
How Many Employees Work at Sudershan Drugs And Intermediates?
Unlock and access historical data on people associated with Sudershan Drugs And Intermediates, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sudershan Drugs And Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sudershan Drugs And Intermediates's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
